Depressive disorder
|
0.470 |
Biomarker
|
disease |
BEFREE |
These findings suggest that selective inhibition of COX-2 ameliorates depression-like behaviors in rat models of depression.
|
31539536 |
2019 |
Depressive disorder
|
0.470 |
AlteredExpression
|
disease |
BEFREE |
1 L-1β, TNF-α and COX-2), increased BDNF expression and neurogenesis, restored the dysfunction of ATP production and oxidative stress in inflammation- induced depression.
|
31022424 |
2019 |
Depressive disorder
|
0.470 |
Biomarker
|
disease |
BEFREE |
Cytosolic phospholipase A2 (cPLA2) and cyclo-oxygenase-2 (COX-2) are the key enzymes in the metabolism of polyunsaturated fatty acids (PUFAs), which in turn may play an important role in inflammation and somatic symptoms in depression.
|
28108057 |
2018 |
Depressive disorder
|
0.470 |
Biomarker
|
disease |
BEFREE |
Hippocampal CA1 βCaMKII mediates neuroinflammatory responses via COX-2/PGE2 signaling pathways in depression.
|
30526621 |
2018 |
Depressive disorder
|
0.470 |
Biomarker
|
disease |
PSYGENET |
There is also some evidence indicative of a role of genetic variants of the enzymes, Cyclo-oxygenase2 (COX-2) and Phospholipase2 (PLA2), in the aetiology of depression.
|
22580182 |
2013 |
Depressive disorder
|
0.470 |
Biomarker
|
disease |
BEFREE |
There is also some evidence indicative of a role of genetic variants of the enzymes, Cyclo-oxygenase2 (COX-2) and Phospholipase2 (PLA2), in the aetiology of depression.
|
22580182 |
2013 |
Depressive disorder
|
0.470 |
Biomarker
|
disease |
PSYGENET |
The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder.
|
22331023 |
2012 |
Depressive disorder
|
0.470 |
Biomarker
|
disease |
PSYGENET |
Polymorphism -765 G/C in COX-2-encoding gene promoter is associated with development of Alzheimer's disease, depression, carcinoma of the pancreas in smokers, breast cancer and rheumatoid arthritis.
|
21655952 |
2012 |
Depressive disorder
|
0.470 |
GeneticVariation
|
disease |
BEFREE |
Polymorphism -765 G/C in COX-2-encoding gene promoter is associated with development of Alzheimer's disease, depression, carcinoma of the pancreas in smokers, breast cancer and rheumatoid arthritis.
|
21655952 |
2012 |
Depressive disorder
|
0.470 |
Biomarker
|
disease |
PSYGENET |
Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels.
|
20034614 |
2010 |
Depressive disorder
|
0.470 |
Biomarker
|
disease |
PSYGENET |
Functional polymorphism of cyclooxygenase-2 gene (G-765C) in depressive patients.
|
20588070 |
2010 |
Depressive disorder
|
0.470 |
AlteredExpression
|
disease |
BEFREE |
COX-2 overexpression was observed in 12 of 77 (15.6%) DP and there was no significant difference between DPdep (3 of 23, 13.0%) and DPpo (9 of 54, 16.7%).
|
12397273 |
2002 |
Depressive disorder
|
0.470 |
Biomarker
|
disease |
HPO |
|
|
|